UBS Group AG - REVIVA PHARMACEUTCLS HLDGS I ownership

REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 8 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of REVIVA PHARMACEUTCLS HLDGS I
ValueSharesWeighting
Q1 2023$1,670
+67.0%
1,670
-75.8%
0.00%
Q3 2022$1,0006,901
+1501.2%
0.00%
Q2 2022$0431
+84.2%
0.00%
Q3 2021$0234
+37.6%
0.00%
Q2 2021$0
-100.0%
170
-98.6%
0.00%
Q1 2021$6,000
+500.0%
12,457
+1070.8%
0.00%
Q4 2020$1,0001,0640.00%
Other shareholders
REVIVA PHARMACEUTCLS HLDGS I shareholders Q2 2022
NameSharesValueWeighting ↓
BlueCrest Capital Management Ltd 1,235,000$222,0000.01%
Arena Investors LP 85,000$15,0000.01%
UBS Group AG 431$00.00%
AQR Arbitrage LLC 55,839$10,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Walleye Trading LLC 65,752$12,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 57,064$10,0000.00%
Walleye Capital LLC 89,623$16,0000.00%
View complete list of REVIVA PHARMACEUTCLS HLDGS I shareholders